Total item
Cart Subtotal
$0.00 Biological Activity
AT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
Targets
| Target | Value |
|---|---|
| CDK9/CyclinT | IC50: <10nM |
| CDK5/p35 | IC50: 13nM |
| CDK2/CyclinA | IC50: 47nM |
| GSK-3β | IC50: 89nM |
| CDK4/CyclinD1 | IC50: 100nM |
| CDK6/CyclinD3 | IC50: 170nM |
| CDK1/CyclinB | IC50: 210nM |
| CDK3/CyclinE | IC50: 360nM |
| PI3Kβ | IC50: >1μM |
| PLK3 | IC50: >1μM |
| RET | IC50: >1μM |
| SGK | IC50: >1μM |
| TrkB | IC50: >1μM |
| JAK2 | IC50: >1μM |
| CDK7/CyclinH/MAT1 | IC50: 2.4μM |
| SAPK2A(p38α) | IC50: >10μM |
| p70S6K | IC50: >10μM |
| PDGFR | IC50: >10μM |
| PDK-1 | IC50: >10μM |
| PKBβ | IC50: >10μM |
| VEGFR1 | IC50: >10μM |
| AuroraA | IC50: >10μM |
| c-Abl | IC50: >10μM |
| c-Src | IC50: >10μM |
| Chk1 | IC50: >10μM |
| EGFR | IC50: >10μM |
| FGFR3 | IC50: >10μM |
| IR | IC50: >10μM |
| JNK2 | IC50: >10μM |
| MAPK1 | IC50: >10μM |
| MEK1 | IC50: >10μM |
| Met | IC50: >10μM |
| In vitro (25°C) | DMSO | 10 mg/mL (26.16 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| In vivo | 30% propylene glycol, 5% Tween 80, 65% D5W | 30 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.88 mL | 119.42 mL | 238.83 mL |
| 0.5 mM | 4.78 mL | 23.88 mL | 47.77 mL |
| 1 mM | 2.39 mL | 11.94 mL | 23.88 mL |
| 5 mM | 0.48 mL | 2.39 mL | 4.78 mL |
*The above data is based on the productmolecular weight 418.7 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11313 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 418.7 |
| Formula | C16H17Cl2N5O2.HCl |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 902135-91-5 |
| Synonyms | AT 7519, AT-7519 |
| SMILES | C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl.Cl |
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
PD 0332991 HCl (Palbociclib)
PD 0332991 HCl is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activit…
Kenpaullone
Kenpaullone is a potent inhibitor of CDK1/cyclin B (IC₅₀ = 400 nM), CDK2/cyclin A (IC₅₀ = 680nM) , CDK5 (IC₅₀ = 850nM) and with …
NVP-LCQ195
NVP-LCQ195 is a small molecule heterocyclic inhibitor of CDK1, CDK2, CDK3 and CDK5 with IC50 of 1-42 nM.
BS-181 HCl
BS-181 HCl is a potential anti-tumor agent as CDK7 inhibitor.
P276-00
P276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM, respectively. In Phase 2/3
R547
R547 is a novel, selective inhibitor of cell cycle and transcriptional cyclin dependent kinases (CDKs) (Ki = 1, 3, and 1 nM for CDK1, CDK2, …
CVT-313
CVT-313 is a potent, selective, reversible, and ATP-competitive inhibitor of CDK2 (IC50 = 0.5 uM for Cdk2/A and Cdk2/E; 4.2 uM for Cdk1/B; 2…
PHA-793887
PHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity ag…
Keywords:buy AT7519 HCl | AT7519 HCl Supplier | purchase | cost | manufacturer | order | distributor | buy 902135-91-5| 902135-91-5 Supplier | purchase 902135-91-5 | 902135-91-5 cost | 902135-91-5 manufacturer | order 902135-91-5 | 902135-91-5 distributor
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: [email protected]
Not your Region? View all Distributors
Adooq Quality Guarantee
We promise all products perform as described.